Solve CEO Emily Taylor Co-Authors RECOVER Study On Risk of Developing ME/CFS After COVID
Solve CEO Emily Taylor and co-authors from esteemed organizations including the Bateman Horne Center; New York University; the Patient Led Research Collaboration on COVID-19; the University of California, San Francisco; […]
The RECOVER-TLC Event Day Three: How Will We Move Forward?
In 2021, the National Institutes of Health (NIH) launched its ambitious nearly $2 billion RECOVER Initiative, dedicated to finding the root causes of and possible treatments for Long Covid. Solve played […]
The RECOVER-TLC Event Day Two: Prioritization of Interventions, Study Design, and End Points
In 2021, the National Institutes of Health (NIH) launched its ambitious nearly $2 billion RECOVER Initiative, dedicated to finding the root causes of and possible treatments for Long Covid. Solve played […]
Solve, BIO Online Conference Invites Biotech to Join In Fighting Long Covid
This article by Tom Popper originally appeared on Bio.com. While research into Long Covid is offering clues to causes and potential targets for treatment, defeating this debilitating condition, which impacts […]
Understanding Long COVID Across Communities of Color, Including Those Hardest Hit by COVID
The National Institutes of Health (NIH) is hosting a listening session, “Understanding Long COVID Across Communities of Color, Including Those Hardest Hit by COVID” on Friday 1/21 from 2PM – […]
